Showing results (1921-1930 of 2,409) with videos related to
Sort By:
Pageof 241
Microbial Genomics|February 4, 2021
BSGatlas: a unified Bacillus subtilis genome and transcriptome annotation atlas with enhanced information accessAdrian Sven Geissler, Christian Anthon, Ferhat Alkan, et al.Frontiers in Oncology|July 6, 2019
Potential Use of Gluconate in Cancer TherapyMaria E Mycielska, Markus T J Mohr, Katharina Schmidt, et al.Molecular Therapy. Methods & Clinical Development|May 28, 2015
In question: the scientific value of preclinical safety pharmacology and toxicology studies with cell-based therapiesChristiane Broichhausen, Paloma Riquelme, Norbert Ahrens, et al.Leukemia Research|March 15, 2001
Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromesF Wimazal, W R Sperr, M Kundi, et al.Therapeutic Innovation & Regulatory Science|February 25, 2017
Culture and Process Change as a Priority for Patient Engagement in Medicines DevelopmentMarc Boutin, Lode Dewulf, Anton Hoos, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|September 26, 2024
Extrahepatic Bile Duct Organoids as a Model to Study Ischemia/Reperfusion Injury During Liver TransplantationP Kreiner, E Eggenhofer, L Schneider, et al.Journal of Hepatology|August 10, 2005
Activation of dendritic cells by local ablation of hepatocellular carcinomaMona Y Ali, Christian F Grimm, Marcus Ritter, et al.Acta Oncologica (Stockholm, Sweden)|September 13, 2013
Docetaxel, oxaliplatin and capecitabine (TEX regimen) in patients with metastatic gastric or gastro-esophageal cancer: results of a multicenter phase I/II studyAlexander Stein, Dirk Arnold, Peter C Thuss-Patience, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 8, 2013
Inhibition of innate co-receptor TREM-1 signaling reduces CD4(+) T cell activation and prolongs cardiac allograft survivalG Schiechl, S M Brunner, R Kesselring, et al.Trials|May 11, 2023
EnGraft: a multicentre, open-label, randomised, two-arm, superiority study protocol to assess bioavailability and practicability of Envarsus® versus Advagraf™ in liver transplant recipientsD S Wöhl, B James, M Götz, et al.Pageof 241